HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

The frequent development of drug resistance to targeted therapies in cancer patients has stimulated interest in strategies counteracting resistance. Combining immunotherapies with targeted therapies is one such strategy. In this context, we asked whether human NK cells can target melanoma cells that...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Eur J Immunol
Main Authors: Sottile, Rosa, Pangigadde, Pradeepa N., Tan, Thomas, Anichini, Andrea, Sabbatino, Francesco, Trecroci, Francesca, Favoino, Elvira, Orgiano, Laura, Roberts, James, Ferrone, Soldano, Kärre, Klas, Colucci, Francesco, Carbone, Ennio
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2015
נושאים:
Immunomodulation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4832274/
https://ncbi.nlm.nih.gov/pubmed/26564811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201445289
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים